Ureteral Stents Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product Type, Application, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Ureteral Stents Market size was more than USD 546.34 Million in 2026 and is set to grow at 6.36% CAGR between 2027 and 2036, exceeding USD 1.01 Billion by 2036. The industry revenue for 2027 is calculated at USD 575.84 Million.
Get more details on this report
Request Free Sample ReportUreteral Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America held 42.93% in 2026, supported by advanced urological infrastructure, established surgical capabilities, and strong adoption of minimally invasive procedures.
- Asia Pacific is the fastest-growing region as healthcare investment, hospital infrastructure, disorder awareness, minimally invasive interventions, and advanced medical-device adoption expand.
Segment Momentum
- Hospitals held 51.41% of the market in 2026 due to their high volume of urological procedures, advanced diagnostic capabilities, specialized expertise, and comprehensive inpatient and emergency care services.
- Ambulatory surgical centers are the fastest-growing end-use segment as demand increases for minimally invasive outpatient procedures, shorter treatment times, and more cost-efficient urological care.
Market Expansion Drivers
- Rising urological disorder prevalence driving demand for ureteral stent procedures
- Expanding preference for minimally invasive urology procedures increasing stent adoption
- Advancements in biocompatible materials improving stent safety and patient outcomes
Leading Market Participants
- Key companies in the ureteral stents market include Boston Scientific Corporation (United States), Cook Medical LLC (United States), B. Braun Melsungen AG (Germany), Coloplast A/S (Denmark), Teleflex Incorporated (United States), Olympus Corporation (Japan), Becton, Dickinson and Company (United States), Medtronic plc (Ireland), ConvaTec Group plc (United Kingdom), Allium Medical Solutions Ltd. (Israel)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 546.34 Million
- 2027 Estimated Market Size: USD 575.84 Million
- Projected Market Size: USD 1.01 Billion by 2036
- Growth Forecast: 6.36% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Double Pigtail (Product Type) | Kidney Stones (Application) | Metal Stents (Material)
- Emerging Opportunity Segment: Ambulatory Surgical Centers (End-use) | Double Pigtail (Product Type) | Kidney Stones (Application) | Polyurethane Stents (Material)
Market Growth Drivers and Industry Trends
Rising urological disorder prevalence driving demand for ureteral stent procedures
The increasing occurrence of kidney stones, urinary tract obstructions, and related urological conditions is creating sustained demand for effective treatment options, which will drive the ureteral stents market growth. Ureteral stents are widely used to restore urine flow, relieve blockages, and support recovery before or after various urological interventions. Greater awareness of early diagnosis and improved access to specialized urology services are encouraging healthcare providers to adopt these devices more frequently as part of comprehensive patient management.
Expanding preference for minimally invasive urology procedures increasing stent adoption
Advancements in endoscopic techniques and modern surgical technologies are encouraging physicians to favor minimally invasive approaches, supporting the ureteral stents market growth. Ureteral stents are routinely incorporated into these procedures to facilitate drainage, reduce postoperative complications, and improve patient comfort during recovery. Their compatibility with minimally invasive treatment pathways enables healthcare providers to achieve effective clinical outcomes while reducing hospital stays and procedural complexity across a variety of urological conditions.
Advancements in biocompatible materials improving stent safety and patient outcomes
Continuous innovation in biomaterial engineering is enhancing the clinical performance of urinary implants, which will boost the ureteral stents market demand. Modern stents are designed with advanced biocompatible materials that improve flexibility, reduce irritation, and minimize the risk of encrustation or infection during extended implantation. These material improvements support better patient tolerance while enabling healthcare professionals to manage complex urological conditions with greater confidence and procedural reliability.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising urological disorder prevalence driving demand for ureteral stent procedures | 2% | High | North America, Europe | High | Near Term |
| Expanding preference for minimally invasive urology procedures increasing stent adoption | 1.7% | High | Asia Pacific | High | Near Term |
| Advancements in biocompatible materials improving stent safety and patient outcomes | 1.5% | Moderate | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the ureteral stents market, North America held the largest share of 42.93% in 2026. The region benefits from advanced urological care infrastructure, established diagnostic and surgical capabilities, and strong adoption of minimally invasive procedures. A well-developed healthcare system and greater awareness of urinary tract disorders support the use of ureteral stents in managing obstruction and facilitating urinary drainage, while continued advances in stent design and materials are helping improve clinical outcomes and patient management.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to experience the fastest growth, supported by expanding access to urological treatment and increasing healthcare investment across emerging economies. Rising awareness of kidney and urinary tract disorders, improving hospital infrastructure, and greater availability of minimally invasive interventions are broadening the patient base for ureteral stents. At the same time, the gradual modernization of healthcare systems and increasing adoption of advanced medical devices are creating a stronger foundation for market expansion across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Clinical Innovation AdoptionThe U.S. ureteral stents market benefits from broad adoption of minimally invasive urological procedures and continuous product refinement. Healthcare providers in the U.S. are incorporating advanced stent designs that improve patient comfort, procedural efficiency, and clinical outcomes.
Germany 🇩🇪
Procedure Quality EnhancementGermany emphasizes ureteral stents that support precision urological procedures and consistent clinical performance across healthcare facilities. Medical providers in Germany increasingly value innovations that reduce complications and simplify postoperative patient management.
Japan 🇯🇵
Patient Comfort SolutionsJapan focuses on ureteral stents designed to improve patient experience while supporting efficient management of urinary tract conditions. Healthcare institutions in Japan are adopting materials and coatings that enhance biocompatibility and reduce treatment-related discomfort.
South Korea 🇰🇷
Advanced Urology PracticeSouth Korea continues expanding the use of ureteral stents within technologically advanced urology services and minimally invasive treatment pathways. Hospitals in South Korea are seeking devices that support procedural precision and streamlined patient care.
France 🇫🇷
Hospital Care OptimizationFrance prioritizes ureteral stents that integrate effectively with standardized hospital treatment protocols and quality care initiatives. Healthcare providers in France are evaluating products that balance procedural efficiency with improved long-term patient management.
Italy 🇮🇹
Specialized Urology SupportItaly maintains steady demand for ureteral stents across specialized urology centers managing stone disease and urinary tract disorders. Medical facilities in Italy are adopting product designs that facilitate reliable placement while supporting efficient follow-up care.
Segment Leadership and Growth Trends
Ureteral Stents Market Share (%), End-use, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals accounted for 51.41% of the ureteral stents market in 2026, making them the largest end-use segment. Their leading position is supported by the high volume of urological procedures performed in hospital settings, along with the availability of advanced diagnostic equipment, specialized urology departments, and multidisciplinary clinical expertise. Hospitals are also the preferred treatment centers for patients with complex urinary tract disorders and post-surgical care requirements, contributing to sustained demand for ureteral stents. In addition, their ability to manage emergency interventions and comprehensive inpatient services further reinforces segment dominance.
Ambulatory surgical centers are emerging as the fastest-growing end-use segment due to the increasing preference for minimally invasive urological procedures performed in outpatient settings. These facilities offer shorter procedure times, reduced hospital stays, and improved operational efficiency while maintaining high standards of patient care. Growing acceptance of same-day surgical treatments, combined with efforts to lower healthcare costs and expand access to specialized urology services, continues to accelerate the adoption of ureteral stents in ambulatory surgical centers.
Product Type Segment Analysis: Double Pigtail (Largest & Fastest-Growing Segment)
Holding the largest share of the ureteral stents market, the double pigtail segment captured 40.82% of the market share in 2026, while also representing the fastest-growing product type. Its widespread clinical adoption is driven by the design's ability to provide secure placement within the urinary tract, reducing the likelihood of stent migration and maintaining effective urine drainage. The configuration is suitable for managing a broad range of urological conditions, including post-operative drainage and ureteral obstruction. Continued preference among healthcare professionals for reliable, well-established stent designs and the growing use of minimally invasive urological procedures further strengthen the segment's market position.
Application Segment Analysis: Kidney Stones (Largest & Fastest-Growing Segment)
The kidney stones application segment dominated the ureteral stents market, accounting for 36.29% of the market share in 2026, while also emerging as the fastest-growing application. The increasing incidence of kidney stone disease, coupled with rising demand for minimally invasive stone removal procedures, continues to support strong utilization of ureteral stents. These devices play a critical role in maintaining urinary flow before and after treatment, reducing the risk of obstruction and facilitating recovery. Greater awareness of early diagnosis, expanding access to advanced urological care, and ongoing improvements in endoscopic treatment techniques are further contributing to sustained growth in this application segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Product Type | Double Pigtail, Open-ended, Close-ended, Multiloop | Double Pigtail | Double Pigtail |
| Application | Kidney Stones, Kidney Transplant, Urinary Tract Infection, Others | Kidney Stones | Kidney Stones |
| Material | Metal Stents, Polyurethane Stents, Silicon Stents, Hydrogel Stents | Metal Stents | Polyurethane Stents |
Competitive Landscape and Market Positioning
Key companies in the ureteral stents market:
- Boston Scientific Corporation (United States)
- Cook Medical LLC (United States)
- B. Braun Melsungen AG (Germany)
- Coloplast A/S (Denmark)
- Teleflex Incorporated (United States)
- Olympus Corporation (Japan)
- Becton Dickinson and Company (United States)
- Medtronic plc (Ireland)
- ConvaTec Group plc (United Kingdom)
- Allium Medical Solutions Ltd. (Israel)
Product development is reshaping competition in the ureteral stents market as manufacturers focus on improving patient comfort, minimizing complications, and simplifying placement procedures for healthcare professionals. Advances in biomaterials, surface treatments, and stent design are enabling suppliers to address long-standing clinical challenges while supporting longer indwelling periods and easier removal where appropriate. Beyond device innovation, competitive differentiation increasingly depends on physician training, procedural support, and the availability of specialized options suited to varying anatomical and therapeutic requirements. Clinical performance, ease of use, and consistent product quality are therefore becoming more influential than broad portfolio breadth alone in shaping market positioning.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Ureteral Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Dwell Time | Short-Term Stents, Intermediate-Term Stents, Long-Term Stents |
| Placement Approach | Retrograde Placement, Antegrade Placement |
| Coating Technology | Uncoated Stents, Hydrophilic-Coated Stents, Antimicrobial-Coated Stents, Drug-Eluting Stents |
Ureteral Stents Market — report.custom
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Pathways in Urological Care |
|
| Patient-Centric Stent Design Priorities |
|
| Outpatient & Ambulatory Care Opportunities |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the ureteral stents market generate?
What is the forecasted size of the ureteral stents industry?
Why is the shift toward minimally invasive urology procedures increasing ureteral stent adoption?
How are advances in biomaterials strengthening the ureteral stents market?
Why do hospitals dominate the ureteral stents market?
Which end-use segment is growing the fastest in the ureteral stents market?
Why does North America hold the largest share of the ureteral stents market?
How is Asia Pacific driving future growth in ureteral stents?
What are the prominent companies operating in the ureteral stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization